A comprehensive analysis identifies and validates NPC1 as a potential biomarker for prognosis in HCC
Niemann-Pick type C1 protein (NPC1), a key regulator of intracellular cholesterol transport and a transmembrane protein, has been implicated in carcinogenesis, particularly in hepatocellular carcinoma (HCC). Despite the noted association, the specific role of NPC1 in HCC remains underexplored. In th...
Saved in:
| Main Authors: | Xingjun Lu, Tianyao Gou, Xuxing He, Xia Chen, Daqing Yang, Xiaozhen Peng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Genetics |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2025.1588583/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research of the Common-mode Voltage Inhibition for Three-level NPC Inverter
by: DING Guanyuan, et al.
Published: (2015-01-01) -
Deficiency of myeloid NPC1 exacerbates liver injury and fibrosis by impairing macrophage efferocytosis
by: Dongwei Guan, et al.
Published: (2025-06-01) -
Identifying key genes involved in HBV-related hepatocellular carcinoma: diagnose, prognosis, interaction and immune analysis
by: Yan Li, et al.
Published: (2025-08-01) -
Nanomaterials Mediated Enhancement of CAR-T for HCC: Revolutionizing Immunotherapy Strategies
by: Liu X, et al.
Published: (2025-06-01) -
Non-viral HCC miRNA profiling reveals miR-1972 as a potential positive prognostic marker
by: Venkata Ramana Mallela, et al.
Published: (2025-12-01)